<?xml version="1.0" encoding="UTF-8"?>
<courses>
    <course academic_year="2015" course_id="159695" class_number="14714" school_id="fas" section="001" term_code="spring">
        <catalog_info>
            <title short_title="NEUROBIO 101B">Novel Therapeutics in the Central Nervous System</title>
            <prereq>Prerequisite: LS 1a AND MCB 80</prereq>
            <description>Recent advances have elucidated new non-traditional molecular signaling pathways involved in many disorders and diseases in the CNS. This tutorial will focus on examining novel therapeutics and &amp;#39;outside the box&amp;#39; approaches to treat CNS disorders: Alzheimer&amp;#39;s, Autism, Schizophrenia, Traumatic Injury and Multiple Sclerosis. To do this, we will examine primary and clinical literature and explore drug design strategies. Students must complete both terms of this course(parts A and B) within the same academic year in order to receive credit.</description>
            <department code="NEURO">Neurobiology</department>
            <course_group code="NEUROBIO">Neurobiology Neurobiology</course_group>
            <course_type>Seminar</course_type>
            <credits>4</credits>
            <meeting_schedule>
                <meeting days_of_week="Wednesday" end_time="17:29:00" location="" start_time="16:00:00"/>
            </meeting_schedule>
        </catalog_info>
        <staff>
            <person id="d1e182727a1310" role="1" seniority_sort="1">
                <display_name>Catherine Dubreuil</display_name>
            </person>
        </staff>
    </course>
</courses>